The estimated Net Worth of Song Tiewei is at least $26 Tausend dollars as of 28 February 2024. Tiewei Tiewei owns over 4,000 units of BIMI stock worth over $6,742 and over the last 2 years he sold BIMI stock worth over $19,223. In addition, he makes $0 as Chief Executive Officer und Director at BIMI.
Tiewei has made over 2 trades of the BIMI stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 4,000 units of BIMI stock worth $16,320 on 28 February 2024.
The largest trade he's ever made was selling 4,000 units of BIMI stock on 28 February 2024 worth over $16,320. On average, Tiewei trades about 1,181 units every 1 days since 2022. As of 28 February 2024 he still owns at least 337,117 units of BIMI stock.
You can see the complete history of Tiewei Tiewei stock trades at the bottom of the page.
Tiewei Song is the Chief Executive Officer, Director at BIMI.
Song's mailing address filed with the SEC is 1-5-2, NO. 19-3, WENYI ROAD,, SHENHE DISTRICT, SHENYANG, LIAONING, F4, 116001.
Over the last 2 years, insiders at BIMI have traded over $19,223 worth of BIMI stock. The most active insiders traders include Song Tiewei. On average, BIMI executives and independent directors trade stock every 1 days with the average trade being worth of $47. The most recent stock trade was executed by Song Tiewei on 28 February 2024, trading 4,000 units of BIMI stock currently worth $16,320.
bimi international medical inc. (nasdaq: bimi) is an american multinational healthcare products and services provider, offering a broad range of healthcare products and related services. the company currently operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. the wholesale pharmaceuticals segment includes supplying prescription and otc medicines, traditional chinese medicines (“tcm”), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. the wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. medical services include private comprehensive hospitals operating in china. the retail pharmacy segment sells prescription and otc medicines, tcm, healthcare supplies and sundry items to retail customers through its directly-owned pharmacies a
BIMI executives and other stock owners filed with the SEC include: